Two potential cancer therapies developed at the University of Miami have been licensed to startup companies under the umbrella of a Miami Beach-based venture capital firm.

Heat Biologics I and II are being funded and managed by Seed-One Ventures, which is led by managing partner Jeff Wolf, who will initially serve as CEO. He plans to locate the companies in the life science park UM has planned for its medical campus.